STAT+: Injecting cancer patients with genetically engineered viruses could be a ‘rock star’ therapy. Why hasn’t it taken off?
Stacy Erholtz had run out of options.
At the age of 49, she had already been fighting multiple myeloma, a blood cancer, for almost a decade. In that time, she tried — and exhausted — every treatment available to her: traditional chemotherapy, novel drugs, and stem cell transplants.